138 related articles for article (PubMed ID: 35002544)
1. Increase in the Length of Lung Cancer Patient Pathway Before First-Line Therapy: A 6-Year Nationwide Analysis From Hungary.
Kiss Z; Bogos K; Tamási L; Ostoros G; Müller V; Urbán L; Bittner N; Sárosi V; Vastag A; Polányi Z; Nagy-Erdei Z; Knollmajer K; Várnai M; Nagy B; Horváth K; Rokszin G; Abonyi-Tóth Z; Barcza Z; Moldvay J; Gálffy G; Vokó Z
Pathol Oncol Res; 2021; 27():1610041. PubMed ID: 35002544
[No Abstract] [Full Text] [Related]
2. Significant changes in advanced lung cancer survival during the past decade in Hungary: impact of modern immunotherapy and the COVID-19 pandemic.
Kiss Z; Gálffy G; Müller V; Moldvay J; Sárosi V; Pápai-Székely Z; Csada E; Kerpel-Fronius A; Király Z; Szász Z; Hódi G; Polányi Z; Kovács K; Karamousouli E; Knollmajer K; Szabó TG; Berta A; Vokó Z; Rokszin G; Abonyi-Tóth Z; Barcza Z; Tamási L; Bogos K
Front Oncol; 2023; 13():1207295. PubMed ID: 37860193
[TBL] [Abstract][Full Text] [Related]
3. Improvement in Lung Cancer Survival: 6-Year Trends of Overall Survival at Hungarian Patients Diagnosed in 2011-2016.
Bogos K; Kiss Z; Tamási L; Ostoros G; Müller V; Urbán L; Bittner N; Sárosi V; Vastag A; Polányi Z; Nagy-Erdei Z; Daniel A; Vokó Z; Nagy B; Horváth K; Rokszin G; Abonyi-Tóth Z; Barcza Z; Gálffy G; Moldvay J
Pathol Oncol Res; 2021; 27():603937. PubMed ID: 34257563
[No Abstract] [Full Text] [Related]
4. Age and Gender Specific Lung Cancer Incidence and Mortality in Hungary: Trends from 2011 Through 2016.
Tamási L; Horváth K; Kiss Z; Bogos K; Ostoros G; Müller V; Urbán L; Bittner N; Sárosi V; Vastag A; Polányi Z; Nagy-Erdei Z; Daniel A; Nagy B; Rokszin G; Abonyi-Tóth Z; Moldvay J; Vokó Z; Gálffy G
Pathol Oncol Res; 2021; 27():598862. PubMed ID: 34257553
[No Abstract] [Full Text] [Related]
5. Underlying reasons for post-mortem diagnosed lung cancer cases - A robust retrospective comparative study from Hungary (HULC study).
Kiss ZN; Bogos K; Tamási L; Ostoros G; Müller V; Bittner N; Sárosi V; Vastag A; Knollmajer K; Várnai M; Kovács K; Berta A; Köveskuti I; Karamousouli E; Rokszin G; Abonyi-Tóth Z; Barcza Z; Kenessey I; Weber A; Nagy P; Freyler-Fadgyas P; Szócska M; Szegner P; Hilbert L; Géczy GB; Surján G; Moldvay J; Vokó Z; Gálffy G; Polányi Z
Front Oncol; 2022; 12():1032366. PubMed ID: 36505881
[TBL] [Abstract][Full Text] [Related]
6. Impact of a Targeted Project for Shortening of Imaging Diagnostic Waiting Time in Patients with Suspected Oncological Diseases in Hungary.
Papp ZM; Szakács L; Hajivandi SS; Kalina I; Varga E; Kiss G; Solymos F; Takács I; Dank M; Dudás I; Szanka T; Dózsa CL; Rékassy B; Merkely B; Maurovich-Horvat P
Medicina (Kaunas); 2023 Jan; 59(1):. PubMed ID: 36676777
[No Abstract] [Full Text] [Related]
7. Significant Regional Differences in Lung Cancer Incidence in Hungary: Epidemiological Study Between 2011 and 2016.
Gálffy G; Vastag A; Bogos K; Kiss Z; Ostoros G; Müller V; Urbán L; Bittner N; Sárosi V; Polányi Z; Nagy-Erdei Z; Daniel A; Knollmajer K; Várnai M; Szegner P; Vokó Z; Nagy B; Horváth K; Rokszin G; Abonyi-Tóth Z; Pozsgai É; Barcza Z; Moldvay J; Tamási L
Pathol Oncol Res; 2021; 27():1609916. PubMed ID: 34594159
[No Abstract] [Full Text] [Related]
8. Therapeutic preferences and outcomes in newly diagnosed patients with Crohn's diseases in the biological era in Hungary: a nationwide study based on the National Health Insurance Fund database.
Kurti Z; Ilias A; Gonczi L; Vegh Z; Fadgyas-Freyler P; Korponay G; Golovics PA; Lovasz BD; Lakatos PL
BMC Gastroenterol; 2018 Jan; 18(1):23. PubMed ID: 29378524
[TBL] [Abstract][Full Text] [Related]
9. Revising Incidence and Mortality of Lung Cancer in Central Europe: An Epidemiology Review From Hungary.
Bogos K; Kiss Z; Gálffy G; Tamási L; Ostoros G; Müller V; Urbán L; Bittner N; Sárosi V; Vastag A; Polányi Z; Nagy-Erdei Z; Vokó Z; Nagy B; Horváth K; Rokszin G; Abonyi-Tóth Z; Moldvay J
Front Oncol; 2019; 9():1051. PubMed ID: 31709174
[No Abstract] [Full Text] [Related]
10. Lung cancer interval times from point of referral to the acute health sector to the start of first treatment.
Largey G; Ristevski E; Chambers H; Davis H; Briggs P
Aust Health Rev; 2016 Jan; 40(6):649-654. PubMed ID: 26909516
[TBL] [Abstract][Full Text] [Related]
11. The pathway to diagnosis and treatment for surgically managed lung cancer patients.
White V; Bergin RJ; Thomas RJ; Whitfield K; Weller D
Fam Pract; 2020 Mar; 37(2):234-241. PubMed ID: 31665265
[TBL] [Abstract][Full Text] [Related]
12. Examining time intervals between diagnosis and treatment in the management of patients with limited stage small cell lung cancer.
Berthelet E; Truong PT; Lesperance M; Lim JT; Wai ES; MacNeil MV; Liu M; Joe H; Olivotto IA
Am J Clin Oncol; 2006 Feb; 29(1):21-6. PubMed ID: 16462498
[TBL] [Abstract][Full Text] [Related]
13. Effect of time interval from diagnosis to treatment for non-small cell lung cancer on survival: a national cohort study in Taiwan.
Tsai CH; Kung PT; Kuo WY; Tsai WC
BMJ Open; 2020 Apr; 10(4):e034351. PubMed ID: 32327476
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of lung cancer in idiopathic pulmonary fibrosis with single lung transplant versus non-transplanted patients: a retrospective observational study.
Gershman E; Zer A; Pertzov B; Shtraichman O; Shitenberg D; Heching M; Rosengarten D; Kramer M
BMJ Open Respir Res; 2020 Jun; 7(1):. PubMed ID: 32565443
[TBL] [Abstract][Full Text] [Related]
15. Time from presentation to pre-diagnostic chest X-ray in patients with symptomatic lung cancer: a cohort study using electronic patient records from English primary care.
Arendse KD; Walter FM; Pilling M; Zhou Y; Hamilton W; Funston G
Br J Gen Pract; 2021 Apr; 71(705):e273-e279. PubMed ID: 33431382
[TBL] [Abstract][Full Text] [Related]
16. Significant improvement in melanoma survival over the last decade: A Hungarian nationwide study between 2011 and 2019.
Liszkay G; Benedek A; Polgár C; Oláh J; Holló P; Emri G; Csejtei A; Kenessey I; Polányi Z; Knollmajer K; Várnai M; Vokó Z; Nagy B; Rokszin G; Fábián I; Barcza Z; Gyulai R; Kiss Z
J Eur Acad Dermatol Venereol; 2023 May; 37(5):932-940. PubMed ID: 36785988
[TBL] [Abstract][Full Text] [Related]
17. Time intervals and routes to diagnosis for lung cancer in 10 jurisdictions: cross-sectional study findings from the International Cancer Benchmarking Partnership (ICBP).
Menon U; Vedsted P; Zalounina Falborg A; Jensen H; Harrison S; Reguilon I; Barisic A; Bergin RJ; Brewster DH; Butler J; Brustugun OT; Bucher O; Cairnduff V; Gavin A; Grunfeld E; Harland E; Kalsi J; Knudsen AK; Lambe M; Law RJ; Lin Y; Malmberg M; Turner D; Neal RD; White V; Weller D
BMJ Open; 2019 Nov; 9(11):e025895. PubMed ID: 31776134
[TBL] [Abstract][Full Text] [Related]
18. Non-small Cell Lung Cancer (NSCLC) in Octogenarians in Clinical Practice.
Koyi H; Hillerdal G; Kölbeck KG; Brodin D; Liv P; Brandén E
Anticancer Res; 2016 Oct; 36(10):5397-5402. PubMed ID: 27798905
[TBL] [Abstract][Full Text] [Related]
19. DIAGNOSTIC AND TACTICAL IMPORTANCE OF STUDYING SHORT CHAIN FATTY ACIDS IN DIFFERENT BIOLOGICAL SUBSTRATES TOOK PLACE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE, LUNG CANCER AND COMMUNITY-ACQUIRED PNEUMONIA DEVELOPED AFTER ANTICANCER THERAPY.
Ardatskaya MD; Ponomareva EV; Shevtsov VV; Evdokimova SA; Odintsov SV
Eksp Klin Gastroenterol; 2016; (11):17-25. PubMed ID: 29889440
[TBL] [Abstract][Full Text] [Related]
20. [Fast diagnostic track for suspected lung cancer: A patient centered approach].
Hardardottir H; Valdimarsdottir UA; Gudbjartsson T; Sigvaldason A; Lund SH; Aspelund T; Hansdottir S; Jonsson S
Laeknabladid; 2017 Apr; 103(4):171-177. PubMed ID: 28401873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
